Europe Clinical Nutrition Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Clinical Nutrition Market is segmented By Route of Administration (Oral and Enteral, Parenteral), By Application, By End User and Geography.

Market Snapshot

Europe Clinical Nutrition Market_1
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 6.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Europe Clinical Nutrition Market is expected to register a CAGR of 6.2% during the forecast period. The major factors attributing to the growth of the market are increasing the prevalence of metabolic disorders, and high spending on healthcare. The actual number of patients undergoing diagnosis of metabolic disorders has increased over the decade, hence, there is an increase in the number of patients diagnosed.

Dietary therapy is critical for normal growth and development, to prevent acute complications, and/or to prevent long-term complications of the given disorder. A failure to follow specific dietary treatment can lead to complications and even death in individuals with metabolic disorders. Nutrition therapy for patients with inherited metabolic disorders is lifelong. The management of patients with many inborn errors of metabolism requires a multidisciplinary approach that combines both nutrition and medical management.

According to the Global Health and Wellness Survey, in 2018, about 70% of individuals who were aged 65 years and over were diagnosed with a metabolic condition in Germany. Furthermore, In these disorders, nutrition therapy is a critical component of the management to prevent acute complications, such as metabolic decompensation, and/or to prevent long-term complications of the given disorder.

Most of the metabolic syndromes result in situations where the body lacks the capability to synthesize non-essential molecules, like vitamins, amino acids, and several molecules involved in metabolic pathways. Most of these conditions can be managed only with supplementation of one or two nutrients. All these factors are helping the market growth. However, there are few factors which may restrain market growth.

Scope of the Report

As per scope of the report, clinical nutrition is an area of medicine that offers treatment of medical disorders caused due to an improper diet or due to the body’s inability to absorb the nutrients available in a normal diet. The Europe clinical nutrition market is segmented by route of administration, application, end user and geography.

By Route of Administration
Oral and Enteral
Parenteral
By Application
Nutritional Support for Malnutrition
Nutritional Support for Metabolic Disorders
Nutritional Support for Gastrointestinal Diseases
Nutritional Support for Cancer
Nutritional Support in Neurological Diseases​
Nutritional Support in Other Diseases
By End User
Pediatric
Adult
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

Oral and Enternal is Expected to Hold the Largest Market share in the Europe Clinical Nutrition Market

Oral clinical nutrition accounts for the largest share, in terms of value, in this segment. Of the three routes of administration available for clinical nutrition, oral and enteral routes are used the most, followed by parenteral route. This is mainly because of the additional cost of processing the product/nutrient involved in enteral/parenteral routes. Until other routes of administration are deemed necessary, physicians mostly prefer the oral route, as it involves lesser complexities and costs, compared to the other two routes of administration. As long as the patients can consume food orally, their stomach and intestine functionalities are not affected, oral route is the preferred route of administration, for clinical nutrition. This is one of the reasons for the large market share, in terms of value, of orally administered clinical nutrition.

As per Germany Federal Statistical Office 2020 report, currently there about 83 million population in Germany. of these 16.2 million population are above 67 years of age and this number is projected to reach to 21.4 million in 2040. As number of elderly population is expected to increase in near future who are more prone to metabolic, neurological and other disorders which will boost the market over the forecast period.

Along with this, most of the disease conditions, in which oral route is used for the administration of clinical nutrition, are chronic conditions. For instance, in case of end stage renal disease (ESRD), the patients only have two options: opting for a transplant (which may not always be possible, due to unavailability of donor or even in cases where a donor is found, it could take anywhere between a few months to several years) or undergoing regular hemodialysis. 

Specialized clinical nutrition is prescribed for these patients to reduce the burden on kidneys, such that the production of excretory products, such as creatinine, uric acid, and bilirubin, etcetera, are in control. As a patient may suffer from ERSD for a long duration, the usage of orally administered clinical nutrition in these cases would also be considerably large, thus resulting in large market share, in terms of value.

clinical Nut key trend 1.png

To understand key trends, Download Sample Report

Competitive Landscape

The Europe clinical nutrition market is consolidatd competitive and consists of few major players. In terms of market share, few of the major players are currently dominating the market. Factors such as the increasing prevalence of metabolic diseases the market is expected to grow further more. Hence, few other players are expected to penetrate the market in the coming years. Some of the major players of the market are Abbott Nutrition, Nestle Health Science, Baxter Healthcare, B. Braun Melsungen AG, and Nutricia are among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Metabolic Disorders

      2. 4.2.2 High Spending on Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Unwillingness of Hospitals and In-house Pharmacies/ Dispensaries to Maintain the Required Stock of Clinical Nutrition Products

      2. 4.3.2 Imprecise Perception about Clinical Nutrition

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Route of Administration

      1. 5.1.1 Oral and Enteral

      2. 5.1.2 Parenteral

    2. 5.2 By Application

      1. 5.2.1 Nutritional Support for Malnutrition

      2. 5.2.2 Nutritional Support for Metabolic Disorders

      3. 5.2.3 Nutritional Support for Gastrointestinal Diseases

      4. 5.2.4 Nutritional Support for Cancer

      5. 5.2.5 Nutritional Support in Neurological Diseases​

      6. 5.2.6 Nutritional Support in Other Diseases

    3. 5.3 By End User

      1. 5.3.1 Pediatric

      2. 5.3.2 Adult

    4. 5.4 Geography

      1. 5.4.1 Europe

        1. 5.4.1.1 Germany

        2. 5.4.1.2 United Kingdom

        3. 5.4.1.3 France

        4. 5.4.1.4 Italy

        5. 5.4.1.5 Spain

        6. 5.4.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Nutrition

      2. 6.1.2 Nestle Health Science

      3. 6.1.3 Baxter Healthcare

      4. 6.1.4 B. Braun Melsungen AG

      5. 6.1.5 Nutricia

      6. 6.1.6 Mead Johnson

      7. 6.1.7 Perrigo Company PLC

      8. 6.1.8 Fresenius Kabi

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Clinical Nutrition Market market is studied from 2018 - 2026.

The Europe Clinical Nutrition Market is growing at a CAGR of 6.2% over the next 5 years.

Abbott Nutrition, Nestle Health Science, Baxter Healthcare, B. Braun Melsungen AG, Nutricia are the major companies operating in Europe Clinical Nutrition Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!